Roberta A Diotti - JoVE Visualize

Showing results (1-10 of 19) with videos related to

Pageof 2

Sort By:

Clinical & Developmental Immunology|June 13, 2012

HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic roleGiuseppe Sautto, Nicasio Mancini, Laura Solforosi, et al.

Frontiers in Immunology|February 17, 2023

The initial interplay between HIV and mucosal innate immunityValeria Caputo, Martina Libera, Sofia Sisti, et al.

Antiviral Research|August 18, 2012

Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interferenceGiuseppe Sautto, Nicasio Mancini, Roberta A Diotti, et al.

Journal of Immunology Research|April 17, 2024

The Question of HIV Vaccine: Why Is a Solution Not Yet Available?Martina Libera, Valeria Caputo, Giulia Laterza, et al.

Viruses|June 24, 2022

Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2Elena Criscuolo, Benedetta Giuliani, Davide Ferrari, et al.

Journal of Virology|March 15, 2019

Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected SubjectsElena Criscuolo, Matteo Castelli, Roberta A Diotti, et al.

Emerging Microbes & Infections|January 5, 2021

Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materialsElena Criscuolo, Roberta A Diotti, Roberto Ferrarese, et al.

Viruses|November 22, 2012

Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Mancini Nicasio, Giuseppe Sautto, Nicola Clementi, et al.

Journal of Medical Virology|October 16, 2020

Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjectsElena Criscuolo, Roberta A Diotti, Marta Strollo, et al.

Gut|February 10, 2015

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoproteinGiuseppe A Sautto, Karin Wisskirchen, Nicola Clementi, et al.

Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:

Pageof 2

Clinical & Developmental Immunology|June 13, 2012

HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic roleGiuseppe Sautto, Nicasio Mancini, Laura Solforosi, et al.

Frontiers in Immunology|February 17, 2023

The initial interplay between HIV and mucosal innate immunityValeria Caputo, Martina Libera, Sofia Sisti, et al.

Antiviral Research|August 18, 2012

Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interferenceGiuseppe Sautto, Nicasio Mancini, Roberta A Diotti, et al.

Journal of Immunology Research|April 17, 2024

The Question of HIV Vaccine: Why Is a Solution Not Yet Available?Martina Libera, Valeria Caputo, Giulia Laterza, et al.

Viruses|June 24, 2022

Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2Elena Criscuolo, Benedetta Giuliani, Davide Ferrari, et al.

Journal of Virology|March 15, 2019

Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected SubjectsElena Criscuolo, Matteo Castelli, Roberta A Diotti, et al.

Emerging Microbes & Infections|January 5, 2021

Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materialsElena Criscuolo, Roberta A Diotti, Roberto Ferrarese, et al.

Viruses|November 22, 2012

Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Mancini Nicasio, Giuseppe Sautto, Nicola Clementi, et al.

Journal of Medical Virology|October 16, 2020

Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjectsElena Criscuolo, Roberta A Diotti, Marta Strollo, et al.

Gut|February 10, 2015

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoproteinGiuseppe A Sautto, Karin Wisskirchen, Nicola Clementi, et al.

Pageof 2